Efficacy of a oil Containing Chamomile in the Treatment Atopic Dermatitis
Phase 2
Recruiting
- Conditions
- Atopic dermatitis.Atopic dermatitis, unspecified
- Registration Number
- IRCT20180108038274N1
- Lead Sponsor
- Sabzevar University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
Infants with atopic dermatitis (based on SCORAD criteria and pediatrician diagnosis)
Good birth weight for age
Lack of underlying diseases and congenital disorders.
Inclination mother's cooperation With the plan
Exclusion Criteria
Major medical diseases (immunodeficiency, growth and development disorders, genetic disorders)
The presence of skin lesions other than eczema in the areas of topical application of the drug
Use of medications that affect eczema during maternal or infant use
Cancellation of the patient to continue the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The severity of the involvement of dermatitis. Timepoint: Before starting treatment and on days 6, 13, 27. Method of measurement: Questionnaire and with SCORAD criteria for atopic dermatitis.;The dryness, redness and irritation. Timepoint: Before starting treatment and on days 6, 13, 27. Method of measurement: Questionnaire.;Pruritus rate. Timepoint: Before starting treatment and on days 6, 13, 27. Method of measurement: Questionnaire.;Insomnia and restlessness of infants. Timepoint: Before starting treatment and on days 6, 13, 27. Method of measurement: Questionnaire.
- Secondary Outcome Measures
Name Time Method Quality of Life. Timepoint: Before starting treatment and days 6, 13 and 27. Method of measurement: questionnaire.